EGFR and cancer: Indeed, our mechanistic study also shows that rCAF-secreted TGFα activates the EGFR/Src/STAT3 signaling pathway in cancer cells, which in turn increases cell survival and prohibits p53/caspase-3 dependent apoptosis during chemotherapy treatment.